Feline Analgesic

Luoda is developing a formulation for pain relief in cats with significant potential for products with enhanced efficacy, safety and convenience as compared to existing treatments.

Otic Combo

Luoda is developing a combination product comprising antibacterial, antifungal and anti-inflammatory agents in gel form, administered as a single long acting application into the dog's ear.

Cardiovascular Combination

A flavoured oral liquid combination formula administering common drugs used to better control the animal's heart failure.


Luoda is developing an injection which will have a significantly more lasting effect than the equivalent oral commercial products

Bovine Mastitis

Luoda has developed a mastitis challenge model of Streptococcus uberis, one of the most common causes of mastitis worldwide. A challenge model of Staphylococcus aureus is also under development.

Pimobendan Liquid

A flavoured oral liquid formulation of pimobendan to improve administration, compliance and effectiveness of medication to treat congestive heart failure in dogs.


Luoda benefits from a truly balanced pipeline, combining active pharmaceutical ingredients (APIs) which are already familiar to the regulator which means the registration process is relatively low risk and more rapid, as well as actives still in early development but whose, commercial potential is enormous.